1Hansen ND.AmpC beta-lactamases:what do we need to know for the future? J Antimicrob Chemother,2003,52:2-4.
2Livermore DM,Brown DF.Detection of beta -lactamase-mediated resistance.J Antimicrob Chemother,2001.48:S59-S64.
3Manchanda V,Singh NP.Occurrence and detection of AmpC beta-lactamases among gram-negtive clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital,Deli,India.J Antimicrob Chemother,2003,51:415-418.
5Coudron P,Hanson ND,Climo MW.Occurrence of extended-spectrum and AmpC beta-lactamases in bloodstream isolates of Klebsiella pneumoniae:isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC beta-lactamases.J Clin Microbiol,2003,41:772-777.
6Reisbig MD,Hossain A,Hanson ND.Factors influencing gene expression and resistance for Gram-negative organisms expressing plasmid-encoded ampC genes of Enterobacter origin.J Antimicrob Chemother,2003,51:1141-1151.
7Sanchez S,McCrackin SMA,Hudson CR,et al.Characterization of multidrug-resistant Escherichia coli isolates associated with nosocomial infections in dogs.J Clin Microbiol,2002,40:3586-3595.
8Pai H,Kang CI,Byeon JH,et al.Epidemiology and clinical features of bloodstream infections caused by AmpC-type-Beta-lactamases-producing Klebsiella pneumoniae.Antimicrob Agents Chemother,2004,48:3720-3728.
9Bonomo RA,Liu J,Chen Y,et al.Inactivation of CMY-2 beta-lactamases by tazobactam:inial mass spectroscopic characterization.Biochim Biophys Acta,2001,1547:196-205.
10Doi Y,Wachino JY,Ishiguro M,et al.Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins.Antimicrob Agents Chemother,2004,48:2652-2658.
二级参考文献17
1Bush K, Jacoby GA, Medeiros AA. A functional classification for β-lactoamases and its correlation with molecular structure. Antimicrob Agents Chemother, 1995,39:1211-1214.
2Pai H, Lyu S, Lee JH, et al. Survey of extended-spectrum β-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. J Clin Microbiol,1999, 37:1758-1763.
3Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC Beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol, 2000,38:1791-1796.
4Kopp U, Wiedemann B, Lindquist S, et el. Sequences of wide-type and mutant ampD genses of Citrobacter freundii and Enterobacter cloacae. Antimicrob Agents Chemother, 1993,224-228.
4Manchanda V,Singh NP. Occurrence and detection of AmpC betalactamases among Gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Deli, India[J]. J Antimicrob Chemother, 200a, 51(5): 415-418.
5NCCLS. Screening and confirmatory tests for ESBLs in Klebsiella pneumoniae , K. oxytoca , and Escherichia coli [ S]. Wayne: NCCLS,2002.46.
6Manchanda V,Singh NP.Occrrence and detection of AmpC betalacta-mases among gram-negtive clinical isolates using a modified three-di-mensional test at Guru Tegh Bahadur Hospital,Deli,India. Journal of Antimicrobial Chemotherapy . 2003
7Screening and Confirmatory Tests for ESBLs in Klebsiella pneumoniae Kwxytoca,and Escherichia coli. National Committee for Clinical Laboratory Standards . 2002
8Coudron PE,Moland ES,and Thomson KS.Occurrence and Detection ofAmpC Beta-Lactamases among Escherichia coli,Klebsiella pneumoni-ae,and Proteus mirabilisIsolates at a Veterans Medical Center. Jour-nal of Clinical Microbiology . 2000
